SEARCH

SEARCH BY CITATION

References

  • 1
    Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. British Medical Journal 1995; 310: 45254.
  • 2
    Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. In: Gardner MJ, Altman DG, editor(s). Statis-tics with confidence. London : British Medical Journal 1989; 83100.
  • 3
    Higgins JPT, Green S. Principles of meta-analysis. In: Higgins JPT, Green S, editor(s). Cochrane handbook for systemic reviews of interventions. Cochrane Book Series. John Wiley and Sons Ltd, West Sussex. 2009.
  • 4
    McQuay H, Moore R. An Evidence-Based Resource for Pain Relief. Oxford : Oxford University Press, 1998.
  • 5
    Schechtman E. Odds ratio, relative risk, absolute risk reduction, and the number needed to treat-which of these should we use Value In Health 2002; 5: 43136.
    Direct Link:
  • 6
    McQuay HJ, Moore RA. Placebo. Postgraduate Medical Journal 2005; 81: 15560.
  • 7
    Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA, editor(s). Systematic reviews in pain research: methodology refined. Seattle : IASP Press, 2008: 1524.
  • 8
    Clarke R, Derry S, Moore RA. Single dose oral etoricoxib for acute postoperative pain in adults. Cochrane Database of Systematic Reviews 2012;(4). Art. No.: CD004309. doi: 10.1002/14651858.CD004309.pub3.
  • 9
    von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bulletin of the World Health Organization 2007; 85: 86772.
  • 10
    Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2012;(4). Art. No.: CD006103. doi: 10.1002/14651858.CD006103.pub6.
  • 11
    DiNisio M, Porreca E, Ferrante N, Otten HM, Cuccurullo F, Rutjes AWS. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Cochrane Database of Systematic Reviews 2012;(2). Art. No.: CD008500. doi: 10.1002/14651858.CD008500.pub2.
  • 12
    Howlett A, Ohlsson A, Plakkal N. Inositol for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 2012;(3). Art. No.: CD000366. doi: 10.1002/14651858.CD000366.pub2.
  • 13
    Martí-Carvajal AJ, Karakitsiou DE, Salanti G. Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases. Cochrane Database of Systematic Reviews 2012;(3). Art. No.: CD004887. doi: 10.1002/14651858.CD004887.pub3.
  • 14
    Antonio Gómez-Outes A, Ana Isabel Terleira-Fernández AI, Suárez-Gea ML, Emilio Vargas-Castrillón E. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. British Medical Journal 2012; 344: e3675 doi: 10.1136/bmj.e3675
  • 15
    Kun Jiang, Wei Huang, Xiao-Nan Yang, Qing Xia. Present and future of prophylactic antibiotics for severe acute pancreatitis. World Journal of Gastroenterology 2012; 18: 27984.
  • 16
    Kim WO, Song BM, Kil HK. Efficacy and safety of a lidocaine/tetracaine medicated patch or peel for dermatologic procedures: a meta-analysis. Korean Journal of Anesthesiology 2012; 62: 43540.
  • 17
    Suissa D, Brassard P, Smiechowski B, Suissa S. Number needed to treat is incorrect without proper time-related considerations. Journal of Clinical Epidemiology, 2012; 65(1): 426.
  • 18
    Suissa S. Calculation of number needed to treat. New England Journal of Medicine 2009; 361(4): 4245.
  • 19
    Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. British Medical Journal 2011; 3(42): d549. doi: 10.1136/bmj.d549.